CNXC Stock Forecast & Price Target

Concentrix Corp is projected to experience revenue and non-GAAP EPS growth in fiscal 2026 and 2027, driven by market share expansion and a strategic shift toward high-value solutions. The company has shown significant progress in its technology offerings, with a notable 61% year-over-year increase in technology wins for fiscal Q1/26, reflecting an effective go-to-market strategy and strong client acceptance. Additionally, total revenue exhibited a 5% year-over-year increase, with constant currency revenue growth of 2%, indicating resilience in its financial performance despite a sequential decline.

Concentrix Corp has experienced significant declines in key financial metrics, with adjusted EBITDA margins dropping year-over-year from 15.8% to 14.1% and sequentially from 14.8% to 13.9% in fiscal Q1/26. Additionally, both adjusted operating margins and gross margins have also shown negative trends, with adjusted operating margins declining from 13.6% year-over-year and gross margins down from 36.1% year-over-year. Furthermore, the company is projecting a year-over-year decline of 6% in EPS alongside a sequential decline of 11%, which is accompanied by persistent issues in key segments such as healthcare and tech due to external factors affecting client engagement.